Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Truvada PrEP Immune Priming in Sex Workers
NCT02593409Phase 4Unknown
- Sponsor
- MRC/UVRI and LSHTM Uganda Research Unit
- Start
- May 2017
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by MRC/UVRI and LSHTM Uganda Research Unit. Status: unknown.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02593409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02593409.